Wells Fargo & Company Neuroone Medical Technologies Corp Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Wells Fargo & Company holds 193 shares of NMTC stock, worth $144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
193
Previous 175
10.29%
Holding current value
$144
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NMTC
# of Institutions
20Shares Held
2.87MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT1.2MShares$899,1840.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA919KShares$689,4900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA222KShares$166,4610.0% of portfolio
-
Mayo Clinic Rochester, MN182KShares$136,3153.91% of portfolio
-
Perkins Capital Management Inc150KShares$112,5000.16% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $12.2M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...